Prevention of cervical cancer in women with HIV

@article{Heard2009PreventionOC,
  title={Prevention of cervical cancer in women with HIV},
  author={Isabelle Heard},
  journal={Current Opinion in HIV and AIDS},
  year={2009},
  volume={4},
  pages={68–73}
}
  • I. Heard
  • Published 1 January 2009
  • Medicine
  • Current Opinion in HIV and AIDS
Purpose of reviewCervical cancer, caused by the human papillomavirus (HPV), is the only cancer that is almost preventable through regular screening. In high-resource, as in low-resource and middle-resource countries, women hit by the AIDS epidemic have a high prevalence of infection with HPV and related disease, including cervical cancer. The question whether cervical screening, which helped to reduce dramatically cervical cancer rates through the detection of precancerous lesions in the… 
Human Papillomavirus Infection in HIV-1 Infected Women in Catalonia (Spain): Implications for Prevention of Cervical Cancer
TLDR
The high prevalence of HPV infection and cervical lesions in the HIV-1–infected population in Catalonia, as well as the low coverage and frequency of screening in this group, means that better preventive efforts are necessary and should include vaccination against HPV.
CERVICAL CANCER IN WOMEN LIVING WITH HIV: A REVIEW OF THE LITERATURE
Corresponding Author: Giuseppe Nunnari, MD, PhD, MPH; e-mail: gnunnari@unime.it Abstract: The introduction of ART had a significant impact on PWLH survival. The incidence of AIDS-defining cancers has
Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women
TLDR
Screen-and-treat utilizing human papillomavirus DNA testing is a simple and effective method to reduce high-grade cervical cancer precursors in HIV-infected women.
Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia
TLDR
The HIV-1 positive population in this study had high multiple HPV infection prevalence and results suggested a greater association between HPV-DNA presence and cytological findings, which could represent useful tools for identifying HIV-positive women at risk of developing cervical lesions.
Cervical cancer risk factors among HIV-infected
TLDR
The prevalence of screening positive lesions or cervical cancer was lower than most previous reports from Africa and the need for more epidemiological studies of cervical cancer and pre-cancerous lesions among HIV-positive women in Africa is highlighted.
Cervical cancer risk factors among HIV-infected Nigerian women
TLDR
The prevalence of screening positive lesions or cervical cancer was lower than most previous reports from Africa and HIV-positive Nigerian women were at a marginally increased risk of cervical pre-cancer and cancer.
Screening of cervical neoplasia in HIV-infected women in India
TLDR
Sequential testing with VIA and VILI is the most feasible screening approach for cervical cancer screening in HIV-infected women in low-resource countries and when HPV testing becomes feasible and affordable, HPV testing followed by VIA/VILI may be considered.
Cervical Cancer Screening in High- and Low-Resource Countries: Implications and New Developments
The implementation of cytology-based screening programs for precancerous lesions of the cervix has decreased the incidence of and mortality from cervical cancer in much of the developed world.
Cervical Screening within HIV Care: Findings from an HIV-Positive Cohort in Ukraine
TLDR
In this high risk population, cervical screening coverage as part of HIV care was low and could be improved by an organised cervical screening programme for HIV-positive women.
The prevention of cervical cancer in HIV-infected women.
TLDR
Certain features of HPV infection in HIV-infected women cannot be explained by increased HPV exposure alone, and a confounding effect of sexual behaviour was evoked.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 58 REFERENCES
Human papillomavirus-related tumors in HIV
TLDR
HIV-positive men and women remain at risk for human papillomavirus-associated cancers, even in the highly active antiretroviral therapy era, and the incidence of anogenital cancers may decline in the future among HIV-positive individuals if they received the human papillaavirus vaccine before they acquired HIV infection.
Evidence for lack of cervical cancer screening among HIV-positive women in Italy.
TLDR
Whereas highly active antiretroviral therapy has been very effective in reducing the incidence of Kaposi sarcoma and non-Hodgkin lymphoma among HIV-positive individuals (Clifford et al., 2005), its effect on HPV infection and HPV-related cancer is modest at best.
Human papillomavirus and cervical cancer
TLDR
The new HPV-oriented model of cervical carcinogenesis should gradually replace older morphological models based only on cytology and histology, and can minimise the incidence of cervical cancer, and the morbidity and mortality it causes, even in low-resource settings.
Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy.
  • S. Franceschi, H. Jaffe
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2007
TLDR
The real opportunity to prevent cervical cancer in HIV-infected women in low-resource countries should not be missed, especially as new, inexpensive screening methods (e.g., rapid human papillomavirus tests) are under evaluation.
Human Papillomavirus and Cervical Cancer
  • E. Burd
  • Medicine
    Clinical Microbiology Reviews
  • 2003
TLDR
Currently, the clearest role for HPV DNA testing is to improve diagnostic accuracy and limit unnecessary colposcopy in patients with borderline or mildly abnormal cytologic test results.
Human papillomavirus vaccines in HIV-positive men and women
TLDR
The safety and efficacy of human papillomavirus vaccines in individuals with HIV need to be assessed to prevent cervical cancer in current and future generations.
Outcomes After Treatment of Cervical Intraepithelial Neoplasia Among Women With HIV
TLDR
Outcomes after treatment of cervical intraepithelial neoplasia (CIN) in women with HIV are described, with most failures and recurrences being low grade but one adenocarcinoma was diagnosed 4.2 years after therapy for CIN.
HPV‐based cervical cancer screening in a population at high risk for HIV infection
TLDR
The usefulness of the HPV test as a screening test for cervical cancer in areas of high HPV prevalence will depend upon local health resource availability, disease priorities and policies regarding clinical case management.
Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy.
TLDR
Analysis of HAART efficacy in preventing CIN onset showed that HAART significantly reduced the risk of developing CIN (hazard ratio, 0.3; p = 0.004), indicating a protective action against the onset of cervical lesions.
Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia.
TLDR
Screening of HIV-infected women in resource-constrained settings like Zambia should be implemented to prevent development of HPV-induced SCC.
...
1
2
3
4
5
...